<DOC>
	<DOC>NCT01626404</DOC>
	<brief_summary>Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with CRT and/or ICD who are candidates for advanced heart failure treatment and obtain insights into patient and physician decisions regarding referral for advanced heart failure therapy.</brief_summary>
	<brief_title>Screening for Advanced Heart Failure Treatment (SEE-HF)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>CRT and or ICD device in place. NYHA class III IV heart failure EF &lt;/= 40% Patient is an outpatient Patient is on optimal medical management as tolerated and as defined by primary care physician. Patient has signed an informed consent for data collection. Age &lt;18 years or &gt;80 years CRT device that has been implanted &lt; 3 months prior to enrollment Coronary revascularization within 3 months prior to enrollment Patient only has ICD but has CRT planned Noncardiac disease resulting in life expectancy &lt; 2 yrs Patient is hospitalized or will be hospitalized at this time Known diagnosis of dementia Patient is currently on dialysis Oxygen dependent lung disease Previously or currently treated with LVAD or heart transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Thoratec Corporation</keyword>
</DOC>